体重与托西利祖马布在类风湿性关节炎中的有效性之间的关联:BSRBR-RABR的结果
Man Fung Tsoi1, Lianne Kearsley-Fleet1, Narges Azadbakht1
1Versus Arthritis Centre for Epidemiology, Centre for Musculoskeletal Research, Division of Musculoskeletal and Dermatological Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.
Rheumatology (Oxford, England)
|September 14, 2024
概括
体重会影响治疗类风湿性关节炎的皮下托西利祖马布的初始反应,但不会影响药物持续性. 医疗保健提供者应监测患者的体重,以获得最佳的治疗结果.
科学领域:
- 类风湿病学 类风湿病学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 托西利祖马布是一种IL-6受体抑制剂,用于类风湿性关节炎 (RA).
- 静脉注射 (IV) 和皮下注射 (SC) 两种配方都可用.
- 只有IV托西利祖马布是根据体重调整的,因此需要研究体重对SC配方疗效的影响.
研究的目的:
- 调查体重与托西利祖马布疗效之间的关联.
- 为了比较体重对托西利祖马布响应的影响,基于给药途径 (IV与SC).
主要方法:
- 对来自BSRBR-RA队列的2612名RA患者的分析.
- 根据托西利祖马布的服用途径 (IV或SC) 的分层.
- 结果包括DAS28的6个月变化,DAS28缓解率,EULAR反应和药物持续性,使用调整后的回归模型进行分析.
主要成果:
- 体重与SC托西利祖马布初始反应的小幅减少有关 (DAS28变化).
- 在体重与实现DAS28缓解或EULAR反应之间没有发现显著的关联.
- 体重没有显著影响IV或SCtocilizumab的持续性.
结论:
- 体重会影响RA患者对皮下托西利祖马布的初始治疗反应.
- 观察到的体重对反应的影响是适度的.
- 医生应考虑患者的体重,并促进在tocilizumab治疗的RA患者的健康体重管理.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
120
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
120
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
145
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
145
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
98
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
98
The JAK-STAT Signaling Pathway
8.7K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.7K
T Cell Types and Functions
961
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
961
Autoimmune Disorders
396
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
396


